Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced the expansion of Airtel Mobile Money as a local payment method to include Tanzania and Madagascar. This growth builds on Xsolla’s existing Airtel Mobile Money coverage in Africa, extending secure, mobile-first checkout experiences to more players in two of the continent’s rapidly digitalizing markets. This press release features multimedia. View the full release here: https...

TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their role...

Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indi...

The Mojaloop Foundation and the Central Bank of Liberia (CBL), in collaboration with Singapore-based ThitsaWorks and The AfricaNenda Foundation, today announces the launch of the Liberian Inclusive Instant Payments System (IIPS), a modern real-time interoperable payments platform powered by Mojaloop, the open-source payments infrastructure built to advance digital financial inclusion. IIPS will principally enable mobile money transfers between two Mobile Network Operators, Lone Star Cell MTN an...

Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of a...